Westchester Capital Management (New York)’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Westchester Capital Management (New York)’s Portfolio DMAAR Stock Details DMAAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.6K	Hold	500,000	–	–	﹤0.01%	281
2025 Q4	$79K	Hold	500,000	–	–	﹤0.01%	252
2025 Q3	$109K	Hold	500,000	–	–	0.01%	209
2025 Q2	$62.5K	Buy	+500,000	New	+$64.3K	﹤0.01%	169

Other funds holding DMAAR

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return